Active Filter(s):
Details:
Collaboration will utilize proprietary CBD-Cubed™ transdermal 24-hour delivery technology for multi-specialty patients.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: VerdePharmHealth
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership June 10, 2020